Ultra-hypofractionated adaptive marker-free SBRT (UHF-MRgSBRT) of Prostate Cancer on the 1.5 T Hyprid-MR-Linac: first prospective Analysis of Feasibility and Tolerability
STRAHLENTHERAPIE UND ONKOLOGIE(2022)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要